The Handoff

The Handoff: Your Week in Neurology News - 5/18/17

By

What US hospitals can learn from the ransomware attack on the UK health care system, plus the latest hurdle for Sarepta's DMD drugs.

The Handoff: Your Week in Neurology News - 5/11/2017

By

A new treatment for ALS gets a green light from the FDA as the NIH prepares to take a deep dive into chronic fatigue syndrome.

The Handoff: Your Week in Neurology News - 5/4/17

By

A third of the population has experienced "mini" stroke, but most don't know how to handle it. Plus, catch up on the latest drug price controversy for rare-disease drugs.

The Handoff: Your Week in Neurology News - 4/27/17

By

Did you miss out on AAN? Catch up on the latest science with Neurology Advisor's live coverage, plus learn about the latest FDA approval.

The Handoff: Your Week in Neurology News - 4/20/17

By

A report ties over 4000 children with birth defects to a popular epilepsy drug, while the FDA issues a stern warning about the use of codeine and tramadol in children.

The Handoff: Your Week in Neurology News - 4/13/17

By

The latest studies suggest that silencing the SCA2 gene may help reduce symptoms of ALS and deep brain stimulation may quell tics associated with Tourette's syndrome.

The Handoff: Your Week in Neurology News - 4/6/17

By

Teva's Huntington's chorea drug names a competitive price as other drug makers pursue phase 3 studies in glioblastoma and depression despite disappointing data.

The Handoff: Your Week in Neurology News - 3/31/17

By

Pricing criticism strikes Roche's Ocrevus as the nominee for FDA commissioner comes under fire for potential conflicts of interest.

The Handoff: Your Week in Neurology News - 3/23/17

By

The CDC says we should be paying more attention to fall-related concussion prevention in the elderly while one of the NFL's own heads to Harvard for a neurosurgery residency.

The Handoff: Your Week in Neurology News - 3/16/17

By

Marathon sells off its controversial DMD drug as the FDA stands to double its fees for the drug approval process under the new Trump budget.

The Handoff: Your Week in Neurology News - 3/9/17

By

The Obamacare replacement is here, and opposition is growing among medical groups. Plus, alternative medicine is having its moment at some major hospitals, while telemedicine proves to be a bust for health care costs.

The Handoff: Your Week in Neurology News - 3/2/17

By

While Genentech rolls the dice on a second phase 3 trial for its anti-amyloid agent, a new biotech startup is tapping CRISPR technology to restore dystrophin production in Duchenne muscular dystrophy.

The Handoff: Your Week in Neurology News - 2/23/17

By

Follow timely coverage of the International Stroke Conference right here on Neurology Advisor.

The Handoff: Your Week in Neurology News - 2/16/17

By

Just days after it received FDA approval, Marathon's Emflaza is under fire from critics who claim the price of the Duchenne muscular dystrophy drug is exorbitant.

The Handoff: Your Week in Neurology News - 2/9/17

By

Still feeling aftershocks from its failed Alzheimer's trial, Eli Lilly announced more layoffs while Biogen faces an investigation into its payment programs for its top MS drugs.

The Handoff: Your Week in Neurology News - 2/2/17

By

Traumatic brain injury continues to make major headlines as a new crop of lawsuits hit the docket ahead of Super Bowl LI. Plus, are we too quick to rush to in-human trials? The authors of an op-ed in Nature think so.

The Handoff: Your Week in Neurology News - 1/26/17

By

One US town tries to take Big Pharma to court over the opioid crisis while the FDA continues to approve new, abuse-deterrent opioids. Plus, the first patient with refractory mesial temporal lobe epilepsy has undergone laser ablation surgery as part of the SLATE trial.

The Handoff: Your Week in Neurology News - 1/12/17

By

The medical community questions whether mobile stroke units are sustainable, new research further links concussions with Alzheimer's disease, and a new trial examines the effects of fasting on MS.

The Handoff: Your Week in Neurology News - 1/5/17

By

Happy New Year! Reflect on some of 2016's greatest neurological advances and look forward as institutions like the NIH take on a focused effort to explore new drugs for rare disease, the developing brain, and more.

The Handoff: Your Week in Neurology News - 12/22/16

The FDA has delayed the decision on ocrelizumab after manufacturing issues arise, while it gives the thumbs up to an investigational treatment for complex regional pain syndrome.

The Handoff: Your Week in Neurology News - 12/15/16

By

The NCAA honored the man and ALS patient behind the viral ALS Ice Bucket Challenge, while the UK approved mitochondrial replacement reproductive assistance and Bristol-Myers Squibb faces a $20 million fine for promoting off-label uses of its antipsychotic Abilify.

The Handoff: Your Week in Neurology News - 12/8/16

By

The Handoff: Your Week in Neurology News - 12/8/16

The Handoff: Your Week in Neurology News - 12/1/16

By

While Alzheimer's research may have hit a speed bump, research exploring gender differences in concussion and controversial treatments for autism and PTSD, including MDMA, are moving full-steam ahead.

The Handoff: Your Week in Neurology News - 11/17/16

By

As the neurology world awaits study results from the solanezumab trial, Boston Medical Center is investing in telehealth for epilepsy care and US prisons are administering a questionable $1,000-a-month injection for opioid addiction.

The Handoff: Your Week in Neurology News - 11/10/16

By

The Handoff: Your Week in Neurology News - 11/10/16

The Handoff: Your Week in Neurology News - 11/3/16

By

More lessons from the eteplirsen controversy, a biologic-based assessment for addiction disorders, a virtual, hassle-free trial for a potential ALS treatment, and more.

The Handoff: Your Week in Neurology News - 10/20/16

By

The FDA is still reeling from the Sarepta debacle, while the NFL tweaks its concussion protocol after several early-season concussions reportedly went ignored.

The Handoff: Your Week in Neurology News - 10/13/16

By

The Handoff is a weekly roundup of neurology news covering various developments in subspecialties, as well as pharmaceutical and association and society news.

The Handoff: Your Week in Neurology News - 10/6/16

By

The Handoff is a weekly roundup of neurology news covering various developments in subspecialties, as well as pharmaceutical and association and society news.

The Handoff: Your Week in Neurology News - 9/29/16

By

The Handoff is a weekly roundup of neurology news covering various developments in subspecialties, as well as pharmaceutical and association and society news.

Sign Up for Free e-newsletters